A detailed history of Nuveen Asset Management, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 145,449 shares of KOD stock, worth $900,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,449
Previous 145,449 -0.0%
Holding current value
$900,329
Previous $341,000 11.14%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $5,276 - $12,211
3,769 Added 2.66%
145,449 $442,000
Q3 2023

Nov 14, 2023

SELL
$1.8 - $7.49 $114,181 - $475,120
-63,434 Reduced 30.93%
141,680 $255,000
Q2 2023

Aug 14, 2023

BUY
$4.3 - $9.48 $317,942 - $700,951
73,940 Added 56.37%
205,114 $1.42 Million
Q1 2023

May 15, 2023

BUY
$4.81 - $8.88 $119,336 - $220,312
24,810 Added 23.33%
131,174 $813,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.05 $106,921 - $132,011
-16,399 Reduced 13.36%
106,364 $5.36 Million
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $719 - $1,187
-95 Reduced 0.08%
122,763 $6.18 Million
Q2 2022

Aug 15, 2022

BUY
$5.04 - $9.48 $124,311 - $233,824
24,665 Added 25.12%
122,858 $6.19 Million
Q1 2022

May 16, 2022

SELL
$7.09 - $89.45 $212 - $2,683
-30 Reduced 0.03%
98,193 $4.94 Million
Q4 2021

Feb 14, 2022

SELL
$80.85 - $128.49 $877,060 - $1.39 Million
-10,848 Reduced 9.95%
98,223 $7.86 Million
Q3 2021

Nov 12, 2021

SELL
$81.97 - $106.94 $1.59 Million - $2.07 Million
-19,376 Reduced 15.08%
109,071 $11.2 Million
Q2 2021

Aug 16, 2021

SELL
$77.2 - $126.54 $275,063 - $450,862
-3,563 Reduced 2.7%
128,447 $11.9 Million
Q1 2021

May 17, 2021

SELL
$110.45 - $164.47 $1.09 Million - $1.63 Million
-9,889 Reduced 6.97%
132,010 $15 Million
Q4 2020

Feb 16, 2021

BUY
$60.78 - $154.03 $778,409 - $1.97 Million
12,807 Added 9.92%
141,899 $20.8 Million
Q3 2020

Nov 16, 2020

SELL
$45.05 - $59.27 $4,640 - $6,104
-103 Reduced 0.08%
129,092 $7.64 Million
Q2 2020

Aug 14, 2020

SELL
$42.74 - $66.25 $846,081 - $1.31 Million
-19,796 Reduced 13.29%
129,195 $6.99 Million
Q1 2020

May 14, 2020

BUY
$38.18 - $73.95 $1.32 Million - $2.56 Million
34,621 Added 30.27%
148,991 $7.11 Million
Q4 2019

Feb 14, 2020

SELL
$13.9 - $76.65 $813,997 - $4.49 Million
-58,561 Reduced 33.86%
114,370 $8.23 Million
Q3 2019

Nov 14, 2019

BUY
$10.24 - $17.57 $925,429 - $1.59 Million
90,374 Added 109.47%
172,931 $2.49 Million
Q2 2019

Aug 15, 2019

BUY
$6.2 - $12.0 $511,853 - $990,684
82,557 New
82,557 $966,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $322M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.